| 000 | 01733 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514042621.0 | ||
| 264 | 0 | _c20021118 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1046/j.1365-2141.2002.03753.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeelan, Bridget T | |
| 245 | 0 | 0 |
_aEffect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cSep 2002 |
||
| 300 |
_a1078-81 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigens, CD19 _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aProteins _xgenetics |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTNF Receptor-Associated Factor 6 |
| 650 | 0 | 4 |
_aThrombocytopenia _xdrug therapy |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aTormey, Vincent | |
| 700 | 1 | _aAmlot, Peter | |
| 700 | 1 | _aPayne, Elspeth | |
| 700 | 1 | _aMehta, Atul | |
| 700 | 1 | _aWebster, A David B | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 118 _gno. 4 _gp. 1078-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.2002.03753.x _zAvailable from publisher's website |
| 999 |
_c12081197 _d12081197 |
||